Skip to main content
  • EKSTROM Trial Shows Reduction of Plaque Volume Progression in Patients With CAD Taking Colchicine

    Patients with coronary artery disease (CAD) who receive colchicine have lowered total plaque volume 1-year post-coronary computed tomography angiography (CCTA) compared with placebo, and both treatments have similar amounts of low attenuation plaque, a new analysis shows. 

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details